Literature DB >> 24569229

Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis.

Jinfang Zhang1, Lixin Wan1, Xiangpeng Dai1, Yi Sun2, Wenyi Wei3.   

Abstract

The Anaphase Promoting Complex/Cyclosome (APC/C) is a multi-subunit E3 ubiquitin ligase that primarily governs cell cycle progression. APC/C is composed of at least 14 core subunits and recruits its substrates for ubiquitination via one of the two adaptor proteins, Cdc20 or Cdh1, in M or M/early G1 phase, respectively. Furthermore, recent studies have shed light on crucial functions for APC/C in maintaining genomic integrity, neuronal differentiation, cellular metabolism and tumorigenesis. To gain better insight into the in vivo physiological functions of APC/C in regulating various cellular processes, particularly development and tumorigenesis, a number of mouse models of APC/C core subunits, coactivators or inhibitors have been established and characterized. However, due to their essential role in cell cycle regulation, most of the germline knockout mice targeting the APC/C pathway are embryonic lethal, indicating the need for generating conditional knockout mouse models to assess the role in tumorigenesis for each APC/C signaling component in specific tissues. In this review, we will first provide a brief introduction of the ubiquitin-proteasome system (UPS) and the biochemical activities and cellular functions of the APC/C E3 ligase. We will then focus primarily on characterizing genetic mouse models used to understand the physiological roles of each APC/C signaling component in embryogenesis, cell proliferation, development and carcinogenesis. Finally, we discuss future research directions to further elucidate the physiological contributions of APC/C components during tumorigenesis and validate their potentials as a novel class of anti-cancer targets.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  APC/C E3 ligase; Cell cycle progression; Mouse model; Tumorigenesis; Ubiquitin ligase; Ubiquitin-proteasome system

Mesh:

Substances:

Year:  2014        PMID: 24569229      PMCID: PMC3995847          DOI: 10.1016/j.bbcan.2014.02.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  287 in total

1.  Dual mode of degradation of Cdc25 A phosphatase.

Authors:  Maddalena Donzelli; Massimo Squatrito; Dvora Ganoth; Avram Hershko; Michele Pagano; Giulio F Draetta
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 2.  APC/C regulation of axonal growth and synaptic functions in postmitotic neurons: the Liprin-alpha connection.

Authors:  F Y H Teng; B L Tang
Journal:  Cell Mol Life Sci       Date:  2005-07       Impact factor: 9.261

3.  Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth.

Authors:  Anna Lasorella; Judith Stegmüller; Daniele Guardavaccaro; Guangchao Liu; Maria S Carro; Gerson Rothschild; Luis de la Torre-Ubieta; Michele Pagano; Azad Bonni; Antonio Iavarone
Journal:  Nature       Date:  2006-06-28       Impact factor: 49.962

4.  Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.

Authors:  Christopher J Morrow; Anthony Tighe; Victoria L Johnson; Maria I F Scott; Claire Ditchfield; Stephen S Taylor
Journal:  J Cell Sci       Date:  2005-07-26       Impact factor: 5.285

5.  Acm1 contributes to nuclear positioning by inhibiting Cdh1-substrate interactions.

Authors:  Juan S Martinez; Hana Hall; Matthew D Bartolowits; Mark C Hall
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

6.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

7.  DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells.

Authors:  Akiko Takahashi; Yoshinori Imai; Kimi Yamakoshi; Shinji Kuninaka; Naoko Ohtani; Shin Yoshimoto; Satoshi Hori; Makoto Tachibana; Emma Anderton; Takashi Takeuchi; Yoichi Shinkai; Gordon Peters; Hideyuki Saya; Eiji Hara
Journal:  Mol Cell       Date:  2011-12-15       Impact factor: 17.970

8.  Dynamics of centromere and kinetochore proteins; implications for checkpoint signaling and silencing.

Authors:  Jagesh V Shah; Elliot Botvinick; Zahid Bonday; Frank Furnari; Michael Berns; Don W Cleveland
Journal:  Curr Biol       Date:  2004-06-08       Impact factor: 10.834

9.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

10.  Unattached kinetochores catalyze production of an anaphase inhibitor that requires a Mad2 template to prime Cdc20 for BubR1 binding.

Authors:  Anita Kulukian; Joo Seok Han; Don W Cleveland
Journal:  Dev Cell       Date:  2009-01       Impact factor: 12.270

View more
  51 in total

1.  The role of APC/C(Cdh1) in replication stress and origin of genomic instability.

Authors:  C Greil; J Krohs; D Schnerch; M Follo; J Felthaus; M Engelhardt; R Wäsch
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

2.  BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors.

Authors:  Enrico Derenzini; Patrizia Mondello; Tatiana Erazo; Ana Portelinha; Yuxuan Liu; Mary Scallion; Zahra Asgari; John Philip; Patrick Hilden; Debora Valli; Alessandra Rossi; Hakim Djaballah; Ouathek Ouerfelli; Elisa de Stanchina; Venkatraman E Seshan; Ronald C Hendrickson; Anas Younes
Journal:  Cell Rep       Date:  2018-08-21       Impact factor: 9.423

Review 3.  Targeting Cdc20 as a novel cancer therapeutic strategy.

Authors:  Lixia Wang; Jinfang Zhang; Lixin Wan; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Pharmacol Ther       Date:  2015-04-04       Impact factor: 12.310

Review 4.  Anillin is an emerging regulator of tumorigenesis, acting as a cortical cytoskeletal scaffold and a nuclear modulator of cancer cell differentiation.

Authors:  Nayden G Naydenov; Jennifer E Koblinski; Andrei I Ivanov
Journal:  Cell Mol Life Sci       Date:  2020-09-03       Impact factor: 9.261

5.  Parkin New Cargos: a New ROS Independent Role for Parkin in Regulating Cell Division.

Authors:  David C Stieg; Katrina F Cooper
Journal:  React Oxyg Species (Apex)       Date:  2016

6.  Parkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1.

Authors:  Seung Baek Lee; Jung Jin Kim; Hyun-Ja Nam; Bowen Gao; Ping Yin; Bo Qin; Sang-Yeop Yi; Hyoungjun Ham; Debra Evans; Sun-Hyun Kim; Jun Zhang; Min Deng; Tongzheng Liu; Haoxing Zhang; Daniel D Billadeau; Liewei Wang; Emilie Giaime; Jie Shen; Yuan-Ping Pang; Jin Jen; Jan M van Deursen; Zhenkun Lou
Journal:  Mol Cell       Date:  2015-09-17       Impact factor: 17.970

Review 7.  Posing the APC/C E3 Ubiquitin Ligase to Orchestrate Cell Division.

Authors:  Edmond R Watson; Nicholas G Brown; Jan-Michael Peters; Holger Stark; Brenda A Schulman
Journal:  Trends Cell Biol       Date:  2018-10-25       Impact factor: 20.808

Review 8.  Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy.

Authors:  Jinfang Zhang; Fabin Dang; Junming Ren; Wenyi Wei
Journal:  Trends Biochem Sci       Date:  2018-10-01       Impact factor: 13.807

9.  APC/C and SCF(cyclin F) Constitute a Reciprocal Feedback Circuit Controlling S-Phase Entry.

Authors:  Rajarshi Choudhury; Thomas Bonacci; Anthony Arceci; Debojyoti Lahiri; Christine A Mills; Jennifer L Kernan; Timothy B Branigan; James A DeCaprio; Daniel J Burke; Michael J Emanuele
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

Review 10.  NEDD4: a promising target for cancer therapy.

Authors:  Xiantao Ye; Lixia Wang; Bingxue Shang; Zhiwei Wang; Wenyi Wei
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.